| | Editorial Foreword Ther Clin Risk Manag. 2007 June; 3(2): 211–212. Published online 2007 June. PMCID: PMC1936302 Review Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors Jean-Pierre Armand, Vincent Ribrag, Jean-Luc Harrousseau, and Lauren Abrey Ther Clin Risk Manag. 2007 June; 3(2): 213–224. Published online 2007 June. PMCID: PMC1936303 Original Research Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom Anna Raber, Joan Heras, Joan Costa, Josep Fortea, and Albert Cobos Ther Clin Risk Manag. 2007 June; 3(2): 225–230. Published online 2007 June. PMCID: PMC1936304 Reviews Long-term management of gastroesophageal reflux disease with pantoprazole Theo Scholten Ther Clin Risk Manag. 2007 June; 3(2): 231–243. Published online 2007 June. PMCID: PMC1936305 The safety of etanercept for the treatment of plaque psoriasis Kim A Papp Ther Clin Risk Manag. 2007 June; 3(2): 245–258. Published online 2007 June. PMCID: PMC1936306 Natalizumab: A new treatment for relapsing remitting multiple sclerosis Michael Hutchinson Ther Clin Risk Manag. 2007 June; 3(2): 259–268. Published online 2007 June. PMCID: PMC1936307 Darbepoetin alpha in the treatment of cancer chemotherapy-induced anemia Alberto Grossi, Francesca Balestri, and Simone Santini Ther Clin Risk Manag. 2007 June; 3(2): 269–275. Published online 2007 June. PMCID: PMC1936308 Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation Muammer Kendirci, Emad Salem, and Wayne JG Hellstrom Ther Clin Risk Manag. 2007 June; 3(2): 277–289. Published online 2007 June. PMCID: PMC1936309 Exjade® (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion Maria Domenica Cappellini Ther Clin Risk Manag. 2007 June; 3(2): 291–299. Published online 2007 June. PMCID: PMC1936310 Infliximab in the treatment of Crohn’s disease Gilberto Poggioli, Silvio Laureti, Massimo Campieri, Filippo Pierangeli, Paolo Gionchetti, Federica Ugolini, Lorenzo Gentilini, Piero Bazzi, Fernando Rizzello, and Maurizio Coscia Ther Clin Risk Manag. 2007 June; 3(2): 301–308. Published online 2007 June. PMCID: PMC1936311 Skin and skin structure infections: treatment with newer generation fluoroquinolones Philip Giordano, Kurt Weber, Gail Gesin, and Jason Kubert Ther Clin Risk Manag. 2007 June; 3(2): 309–317. Published online 2007 June. PMCID: PMC1936312 Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B Eugene B Kern, David Sherris, Angelos M Stergiou, Laura M Katz, Lisa C Rosenblatt, and Jens Ponikau Ther Clin Risk Manag. 2007 June; 3(2): 319–325. Published online 2007 June. PMCID: PMC1936313 Montelukast in the management of allergic rhinitis Jaime A Lagos and Gailen D Marshall Ther Clin Risk Manag. 2007 June; 3(2): 327–332. Published online 2007 June. PMCID: PMC1936314 An overview of the clinical use of ondansetron in preschool age children Ira Todd Cohen Ther Clin Risk Manag. 2007 June; 3(2): 333–339. Published online 2007 June. PMCID: PMC1936315 Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST) Christophe Le Tourneau, Eric Raymond, and Sandrine Faivre Ther Clin Risk Manag. 2007 June; 3(2): 341–348. Published online 2007 June. PMCID: PMC1936316 A smarter way to manage asthma with a combination of a long-acting β2-agonist and inhaled corticosteroid Olof Selroos Ther Clin Risk Manag. 2007 June; 3(2): 349–359. Published online 2007 June. PMCID: PMC1936317 |